NCT07729397
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07729397
Title Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30) (ANCILE-30)
Acronym ANCILE-30
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors The Methodist Hospital Research Institute
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.